IJzerman A P, van Vlijmen H W
Center for Bio-Pharmaceutical Sciences, Division of Medicinal Chemistry, Leiden, The Netherlands.
J Comput Aided Mol Des. 1988 Apr;2(1):43-53. doi: 10.1007/BF01532052.
The recent elucidation of the primary structure of the cell membrane-bound beta-adrenoceptor has prompted us to explore putative ligand binding sites on this physiologically important receptor. By minimizing the energies of the 'prototype' ligand propranolol, (part of) the receptor and the proposed ligand-receptor complex with the aid of force field and quantum chemical calculations, we identified amino acid residue Trp313 as a highly probable candidate for interaction with the aromatic moiety of propranolol. The charge distribution on the indole nucleus of another beta-blocker, pindolol, with higher affinity for the beta-adrenoceptor, enables an even stronger interaction with the tryptophan residue. The carboxylic amino acid residue Glu306, located near the extracellular space of the cell membrane, interacts favorably with the positively charged nitrogen atom in the aliphatic side chain of the ligands. Finally, this putative model is discussed in the light of recent findings in mutagenesis studies, and compared to other ideas with respect to ligand-receptor interactions.
近期对细胞膜结合β-肾上腺素能受体一级结构的阐明促使我们探索该生理重要受体上的假定配体结合位点。通过借助力场和量子化学计算使“原型”配体普萘洛尔、(部分)受体以及拟议的配体-受体复合物的能量最小化,我们确定氨基酸残基Trp313是与普萘洛尔芳香部分相互作用的极有可能的候选者。另一种对β-肾上腺素能受体具有更高亲和力的β受体阻滞剂吲哚洛尔的吲哚核上的电荷分布,使其与色氨酸残基的相互作用更强。位于细胞膜细胞外空间附近的羧基氨基酸残基Glu306与配体脂肪族侧链中带正电荷的氮原子发生有利的相互作用。最后,根据诱变研究中的最新发现对该假定模型进行了讨论,并就配体-受体相互作用与其他观点进行了比较。